Nutanix director Sheppard sells 2,800 and 700 shares

Q: How many NTNX shares did director Teresa Gayle Sheppard sell?

Teresa Gayle Sheppard sold 2,800 shares at a weighted average of $73.5570 per share and 700 shares at a weighted average of $74.1450 per share on October 9, 2026. The execution-price ranges were $73.06 to $74.00 and $74.11 to $74.19 per share, respectively.

Q: Were Teresa Gayle Sheppard’s NTNX sales made under a 10b5-1 plan?

Yes. Both sales were effected automatically under a Rule 10b5-1 trading plan adopted on July 10, 2026.

Q: What RSUs are mentioned in Teresa Gayle Sheppard’s NTNX Form 4?

The reported amount includes 4,588 unvested RSUs, which are issuable into Nutanix Class A common stock upon vesting.

Both sales were automatically made under a Rule 10b5-1 trading plan adopted on July 10, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Nutanix, Inc. director Teresa Gayle Sheppard sold 2,800 shares of Class A common stock at a weighted average price of $73.5570 per share and 700 shares at a weighted average price of $74.1450 per share on October 9, 2026. The sales were effected automatically under a Rule 10b5-1 trading plan adopted on July 10, 2026. The execution prices ranged from $73.06 to $74.00 for the first sale and from $74.11 to $74.19 for the second.

Insider Trade Summary 10b5-1

Net Seller: 3,500 shares

Net Sell 2 txns

Insider Sheppard Teresa Gayle

Role Director

Sold 3,500 shs ($258K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock ^{F1, F2, F3}	2,800	$73.557	$206K
Sale	Class A Common Stock ^{F1, F4, F3}	700	$74.145	$52K

Holdings After Transaction: Class A Common Stock — 23,488 shares (Direct)

Footnotes (4)

F1. This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 10, 2026.
F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.06 to $74.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. Includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.
F4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.11 to $74.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Sale quantity: 2,800 shares Weighted average sale price: $73.5570 per share Sale quantity: 700 shares +2 more

5 metrics

Sale quantity 2,800 shares October 9, 2026

Weighted average sale price $73.5570 per share 2,800-share sale on October 9, 2026

Sale quantity 700 shares October 9, 2026

Weighted average sale price $74.1450 per share 700-share sale on October 9, 2026

Unvested RSUs 4,588 RSUs Issuable into Nutanix Class A common stock upon vesting

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, unvested RSUs

3 terms

Rule 10b5-1 trading plan regulatory

"effected automatically pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"reported price in Column 4 is a weighted average sale price"

unvested RSUs financial

"Includes 4,588 unvested RSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTNX shares did director Teresa Gayle Sheppard sell?

Teresa Gayle Sheppard sold 2,800 shares at a weighted average of $73.5570 per share and 700 shares at a weighted average of $74.1450 per share on October 9, 2026. The execution-price ranges were $73.06 to $74.00 and $74.11 to $74.19 per share, respectively.

Were Teresa Gayle Sheppard’s NTNX sales made under a 10b5-1 plan?

Yes. Both sales were effected automatically under a Rule 10b5-1 trading plan adopted on July 10, 2026.

What RSUs are mentioned in Teresa Gayle Sheppard’s NTNX Form 4?

The reported amount includes 4,588 unvested RSUs, which are issuable into Nutanix Class A common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/09/2026 - 04:58 PM Accepted by SEC EDGAR 10/09/2026 - 04:58 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheppard Teresa Gayle

(Last)

(First)

(Middle)

C/O NUTANIX, INC.

1740 TECHNOLOGY DR., SUITE 150

(Street)

SAN JOSE

CALIFORNIA

95110

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutanix, Inc. [ NTNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	10/09/2026		S		2,800⁽¹⁾	D	$73.557⁽²⁾	24,188⁽³⁾	D
Class A Common Stock	10/09/2026		S		700⁽¹⁾	D	$74.145⁽⁴⁾	23,488⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 10, 2026.

2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.06 to $74.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.11 to $74.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Raymond Hum, Attorney in Fact	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR